Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...
Weight-loss jabs such as Ozempic are being hailed as a potential breakthrough in the fight against obesity. Demand, fuelled ...
Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results